Early Rollout Vax Injured Claim Ivermectin Successfully Treated Their Paralysis

[Markinsa]

 

American Conversations Host Christine Dolan speaks with vaccine-injured patients Angelia Desselle and Shawn Vidiella. The two describe how taking Ivermectin has helped with paralysis brought on by the vaccine, as well as with other severe symptoms. Yet, Ivermectin is still being restricted in its use. Both woman have asked for a meeting with Dr. Anthony Fauci.

 

 

[TexasGranny]

This is from NIH: 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823/

 

I'm not posting the entire article - too long - however the following are excerpts:

 

Conclusions:

Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.

 

The evidence base for ivermectin against COVID-19

To date, the efficacy of ivermectin in COVID-19 has been supported by the following:

1. Since 2012, multiple in vitro studies have demonstrated that Ivermectin inhibits the replication of many viruses, including influenza, Zika, Dengue, and others.^9–17

2. Ivermectin inhibits SARS-CoV-2 replication and binding to host tissue through several observed and proposed mechanisms.¹⁸

3. Ivermectin has potent anti-inflammatory properties with in vitro data demonstrating profound inhibition of both cytokine production and transcription of nuclear factor-κB (NF-κB), the most potent mediator of inflammation.^37–39

4. Ivermectin significantly diminishes viral load and protects against organ damage in multiple animal models when infected with SARS-CoV-2 or similar coronaviruses.^31,32

5. Ivermectin prevents transmission and development of COVID-19 disease in those exposed to infected patients.^40–45

6. Ivermectin hastens recovery and prevents deterioration in patients with mild to moderate disease treated early after symptoms.^{45,49–52,61,62}

7. Ivermectin hastens recovery and avoidance of ICU admission and death in hospitalized patients.^{45,51,53,63–66}

8. Ivermectin reduces mortality in critically ill patients with COVID-19.^45,53,63

9. Ivermectin leads to temporally associated reductions in case fatality rates in regions after ivermectin distribution campaigns.⁴⁸

10. The safety, availability, and cost of ivermectin are nearly unparalleled given its low incidence of important drug interactions along with only mild and rare side effects observed in almost 40 years of use and billions of doses administered.⁷⁵

11. The World Health Organization has long included ivermectin on its “List of Essential Medicines.”

 

A summary of the statistically significant results from the above controlled trials are as follows:

Controlled trials in the prophylaxis of COVID-19 (8 studies)

1. All 8 available controlled trial results show statistically significant reductions in transmission.

2. Three RCTs with large statistically significant reductions in transmission rates, N = 774 patients.^44–46

3. Five OCTs with large statistically significant reductions in transmission rates, N = 2052 patients.^40–43,47

 

Controlled trials in the treatment of COVID-19 (19 studies)

1. Five RCTs with statistically significant impacts in time to recovery or hospital length of stay.^{45,49,53,64,65}

2. One RCT with a near statistically significant decrease in time to recovery, P = 0.07, N = 130.⁵⁴

3. One RCT with a large, statistically significant reduction in the rate of deterioration or hospitalization, N = 363.⁴⁹

4. Two RCTs with a statistically significant decrease in viral load, days of anosmia, and cough, N = 85.^57,60

5. Three RCTs with large, statistically significant reductions in mortality (N = 695).^45,60,65

6. One RCT with a near statistically significant reduction in mortality, P = 0.052 (N = 140).⁵³

7. Three OCTs with large, statistically significant reductions in mortality (N = 1688).^51,63,66

 

[nstoolman1]

My 36 yo daughter tested + for CV-19 on Saturday 13th. My wife had previously ordered her standby Ivermectin and had received it that day. We immediately got that and Vit D, C, A.,Quercetin, Zinc and Meletonin. She started that regime that afternoon. Sunday was her worst day. Today she feels like a little congestion but relative good. She took her other test and it came back inconclusive.

 

IVERMECTIN works. 

 

My daughter also went online and her online Dr had prescribed and sent the script to her pharmacy.

She just gave us back her unused script to replace ours.